Squamous Cell Carcinoma of the Cervix: Clinical Trials

6 trials for Squamous Cell Carcinoma of the Cervix, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 1 recruiting, 1 terminated, 1 unknown. 5 Phase 2, 4 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 25Completed 2, Recruiting 1, Terminated 1, Unknown 1
Phase 14Completed 1, Recruiting 1, Terminated 1, Unknown 1

Follow Squamous Cell Carcinoma of the Cervix: new trials by email Literature Review of Squamous Cell Carcinoma of the Cervix trials Research Report on Squamous Cell Carcinoma of the Cervix

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study of IDP-001 in Advanced or Metastatic Solid Tumors
IDP-001 - Advanced Solid Tumor, Metastatic Solid Tumor
Phase 1 / Phase 2RecruitingInduPro, Inc.1322026-07-082026-09-03
SL-279252 (PD1-Fc-OX40L) in Subjects With Advanced Solid Tumors or Lymphomas
SL-279252 - Squamous Cell Carcinoma of the Head and Neck, Melanoma
Phase 1CompletedShattuck Labs, Inc.492019-03-262025-04-02
Avelumab With Valproic Acid in Virus-associated Cancer
Valproic Acid, Avelumab - Cancer That is Associated With a Chronic Viral Infection, p16 Positive SCCHN
Phase 2CompletedAHS Cancer Control Alberta392018-02-072026-11-04
PEN-866 in Patients With Advanced Solid Malignancies
PEN-866 Sodium, fluorouracil, Folinic acid - Carcinoma, Endometrial Adenocarcinoma
Phase 1 / Phase 2UnknownTarveda Therapeutics3402017-08-292022-02-17
A Clinical Trial to Determine the Most Suitable Dose of OPB-111001 in Patients With Advanced Cancer
OPB-111001 - Prostate Cancer, Salivary Gland Cancer
Phase 1 / Phase 2TerminatedOtsuka Novel Products GmbH792014-01-012015-10-20
Concurrent Treatment of Squamous Cell Carcinoma or Adenocarcinoma of the Cervix With CIGB-300 for Local Application
CIGB300 - Squamous Cell Carcinoma of the Cervix, Adenocarcinoma of the Cervix
Phase 2CompletedLaboratorio Elea Phoenix S.A.182011-05-012016-08-02

Narrower conditions

Anus Neoplasms (3)  ·  Carcinoma, Squamous Cell (2)  ·  Squamous Cell Carcinoma of Head and Neck (2)  ·  Breast Neoplasms (1)  ·  Carcinoma (1)  ·  Carcinoma, Non-Small-Cell Lung (1)  ·  Carcinoma, Renal Cell (1)  ·  Carcinoma, Transitional Cell (1)  ·  Endometrial Neoplasms (1)  ·  Esophageal Squamous Cell Carcinoma (1)  ·  Hodgkin Disease (1)  ·  Lymphoma, Large B-Cell, Diffuse (1)  ·  Melanoma (1)  ·  Neoplasm Metastasis (1)  ·  Neoplasms (1)

Broader conditions

Neoplasms by Site (4)  ·  Anus Diseases (3)  ·  Colorectal Neoplasms (3)  ·  Digestive System Diseases (3)  ·  Digestive System Neoplasms (3)  ·  Gastrointestinal Diseases (3)  ·  Gastrointestinal Neoplasms (3)  ·  Head and Neck Neoplasms (3)  ·  Intestinal Diseases (3)  ·  Intestinal Neoplasms (3)  ·  Neoplasms (3)  ·  Neoplasms by Histologic Type (3)  ·  Neoplasms, Glandular and Epithelial (3)  ·  Rectal Diseases (3)  ·  Rectal Neoplasms (3)

Interventions

CIGB-300 (1)  ·  Fluorouracil (1)  ·  Leucovorin (1)  ·  Valproic Acid (1)  ·  avelumab (1)  ·  niraparib (1)

Sponsors

AHS Cancer Control Alberta (1)  ·  InduPro, Inc. (1)  ·  Laboratorio Elea Phoenix S.A. (1)  ·  Otsuka Novel Products GmbH (1)  ·  Shattuck Labs, Inc. (1)  ·  Tarveda Therapeutics (1)

Countries

United States (3)  ·  Canada (2)  ·  Argentina (1)  ·  Belgium (1)  ·  Spain (1)  ·  United Kingdom (1)

Top investigators

Anish Thomas, MD (1)  ·  Johann De Bono, Prof. Dr. (1)  ·  John Walker, MD PhD FRCPC (1)  ·  Sarah Blagden, Dr. (1)

Results publications

PMID 40042547